Table of Contents
ISRN Addiction
Volume 2013 (2013), Article ID 768258, 9 pages
http://dx.doi.org/10.1155/2013/768258
Research Article

Active Drug-Using Women Use Female-Initiated Barrier Methods to Reduce HIV/STI Risk: Results from a Randomized Trial

1Department of Epidemiology, Robert Stempel College of Public Health and Social Work, Florida International University, 11200 SW 8th Street, Miami, FL 33199, USA
2Center for Research on U.S. Latino HIV/AIDS and Drug Abuse (CRUSADA), Florida International University, Miami, FL 33199, USA
3Drexel Hill, PA 19026, USA
4Center for Studies on Addiction, Department of Psychiatry, University of Pennsylvania, Philadelphia, PA 19104, USA
5Regional West Medical Center, Scottsbluff, NE 69361, USA
6HIV/AIDS Prevention Research Division, Department of Psychiatry, University of Pennsylvania, Philadelphia, PA 19104, USA

Received 1 July 2013; Accepted 2 August 2013

Academic Editors: K. F. Corsi and T. F. Kresina

Copyright © 2013 Erica Gollub et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. Joint United Nations Programme on HIV/AIDS (UNAIDS), “UNAIDS global report: report on the global AIDS epidemic,” 2010, http://www.unaids.org/globalreport/global_report.htm.
  2. White House Office of National AIDS Policy, “National HIV/AIDS strategy for the United States,” Washington, DC, USA, The White House, 2010, http://aids.gov/federal-resources/national-hiv-aids-strategy/nhas.pdf.
  3. S. L. Hodder, J. Justman, D. F. Haley et al., “Challenges of a hidden epidemic: HIV prevention among women in the United States,” Journal of Acquired Immune Deficiency Syndromes, vol. 55, supplement 2, pp. S69–S73, 2010. View at Publisher · View at Google Scholar · View at Scopus
  4. F. R. Lashley, “Transmission and Epidemiology of HIV/AIDS: a Global View,” Nursing Clinics of North America, vol. 41, no. 3, pp. 339–354, 2006. View at Publisher · View at Google Scholar · View at Scopus
  5. Centers for Disease Control (CDC) and Department of Health and Human Services Public Health Service, “Disparities in diagnoses of HIV infection between Blacks/African-Americans and other racial/ethnic populations —37 states, 2005–2008,” Morbidity and Mortality Weekly Report, vol. 60, no. 4, pp. 93–98, 2011. View at Google Scholar
  6. K. Fenton, “HIV in the United States today: The numbers. National Summit on HIV Diagnosis, Prevention, Access to Care,” 2010, http://www.hivforum.org/storage/hivforum/documents/2010Summit/Presentations/101117_pl_01_03_fenton.pdf.
  7. A. Lansky, J. T. Brooks, E. Dinenno, J. Heffelfinger, H. I. Hall, and J. Mermin, “Epidemiology of HIV in the United States,” Journal of Acquired Immune Deficiency Syndromes, vol. 55, 2, pp. S64–S68, 2010. View at Publisher · View at Google Scholar · View at Scopus
  8. N. El-Bassel, A. Terlikbaeva, and S. Pinkham, “HIV and women who use drugs: double neglect, double risk,” The Lancet, vol. 376, no. 9738, pp. 312–314, 2010. View at Publisher · View at Google Scholar · View at Scopus
  9. Centers for Disease Control (CDC) and Department of Health and Human Services Public Health Service, “Cases of HIV infection and AIDS in the United States and dependent areas,” HIV/AIDS Surveillance Report no. 19, 2007.
  10. M. Miller, Y. Liao, M. Wagner, and C. Korves, “HIV, the clustering of sexually transmitted infections, and sex risk among African American women who use drugs,” Sexually Transmitted Diseases, vol. 35, no. 7, pp. 696–702, 2008. View at Publisher · View at Google Scholar · View at Scopus
  11. P. P. French, M. Latka, E. L. Gollub, C. Rogers, D. R. Hoover, and Z. A. Stein, “Use-effectiveness of the female versus male condom in preventing sexually transmitted disease in women,” Sexually Transmitted Diseases, vol. 30, no. 5, pp. 433–439, 2003. View at Publisher · View at Google Scholar · View at Scopus
  12. A. Peters, W. Jansen, and F. van Driel, “The female condom: the international denial of a strong potential,” Reproductive Health Matters, vol. 18, no. 35, pp. 119–128, 2010. View at Publisher · View at Google Scholar · View at Scopus
  13. T. M. Exner, J. M. Tesoriero, H. B. Battles et al., “A randomized controlled trial to evaluate a structural intervention to promote the female condom in New York State,” AIDS and Behavior, vol. 16, no. 5, pp. 1121–1132, 2012. View at Publisher · View at Google Scholar · View at Scopus
  14. United Nations Fund for Population Activities (UNFPA), “HIV prevention gains momentum: Success in female condom programming,” 2011, http://www.unfpa.org/public/home/publications/pid/7668.
  15. C. M. Lyles, L. S. Kay, N. Crepaz et al., “Best-evidence interventions: findings from a systematic review of HIV behavioral interventions for US populations at high risk, 2000–2004,” American Journal of Public Health, vol. 97, no. 1, pp. 133–143, 2007. View at Publisher · View at Google Scholar · View at Scopus
  16. W. M. Wechsberg, S. P. Novak, W. A. Zule et al., “Sustainability of intervention effects of an evidence-based HIV prevention intervention for African American women who smoke crack cocaine,” Drug and Alcohol Dependence, vol. 109, no. 1–3, pp. 205–212, 2010. View at Publisher · View at Google Scholar · View at Scopus
  17. W. M. Wechsberg, W. K. K. Lam, W. A. Zule, and G. Bobashev, “Efficacy of a woman-focused intervention to reduce HIV risk and increase self-sufficiency among African American crack abusers,” American Journal of Public Health, vol. 94, no. 7, pp. 1165–1173, 2004. View at Google Scholar · View at Scopus
  18. C. E. Sterk, K. P. Theall, and K. W. Elifson, “Effectiveness of a risk reduction intervention among African American women who use crack cocaine,” AIDS Education and Prevention, vol. 15, no. 1, pp. 15–32, 2003. View at Publisher · View at Google Scholar · View at Scopus
  19. R. Connell, “Theorising gender,” Sociology, vol. 19, no. 2, pp. 260–272, 1985. View at Google Scholar
  20. N. Wallerstein, “Powerlessness, empowerment, and health: implications for health promotion programs,” American Journal of Health Promotion, vol. 6, no. 3, pp. 197–205, 1992. View at Google Scholar · View at Scopus
  21. Boston Women’s Health Book Collective (BWHBC), Our Bodies, Ourselves, New York, NY, USA, Simon and Schuster, 1971.
  22. E. L. Gollub, Z. Stein, and W. El-Sadr, “Short-term acceptability of the female condom among staff and patients at a New York City hospital,” Family Planning Perspectives, vol. 27, no. 4, pp. 155–158, 1995. View at Publisher · View at Google Scholar · View at Scopus
  23. E. L. Gollub, P. French, M. Latka, C. Rogers, and Z. Stein, “Achieving safer sex with choice: studying a women's sexual risk reduction hierarchy in an STD clinic,” Journal of Women's Health and Gender-Based Medicine, vol. 10, no. 8, pp. 771–783, 2001. View at Publisher · View at Google Scholar · View at Scopus
  24. E. L. Gollub, E. L. Brown, M. Savouillan, J. Waterlot, and G. Coruble, “A community-based safer-sex intervention for women: results of a pilot study in south-eastern France,” Culture, Health and Sexuality, vol. 4, no. 1, pp. 21–41, 2002. View at Publisher · View at Google Scholar · View at Scopus
  25. E. L. Gollub, K. M. Morrow, K. H. Mayer et al., “Three city feasibility study of a body empowerment and HIV prevention intervention among women with drug use histories: women FIT,” Journal of Women's Health, vol. 19, no. 9, pp. 1705–1713, 2010. View at Publisher · View at Google Scholar · View at Scopus
  26. L. Van Damme, G. Ramjee, M. Alary et al., “Effectiveness of COL-1492, a nonoxynol-9 vaginal gel, on HIV-1 transmission in female sex workers: a randomised controlled trial,” The Lancet, vol. 360, no. 9338, pp. 971–977, 2002. View at Publisher · View at Google Scholar · View at Scopus
  27. E. L. Gollub, K. Armstrong, T. Boney et al., “Correlates of trichomonas prevalence among street-recruited, drug-using women enrolled in a randomized trial,” Substance Use and Misuse, vol. 45, no. 13, pp. 2203–2220, 2010. View at Publisher · View at Google Scholar · View at Scopus
  28. E. L. Gollub, E. Cyrus-Cameron, K. Armstrong, T. Boney, and S. Chhatre, “Basic body knowledge in street-recruited, active drug-using women enrolled in a “body empowerment” intervention trial,” AIDS Care, vol. 25, no. 6, pp. 732–737, 2013. View at Publisher · View at Google Scholar
  29. S. A. Sanders, M. Reece, D. Herbenick, V. Schick, B. Dodge, and J. D. Fortenberry, “Condom use during most recent vaginal intercourse event among a probability sample of adults in the United States,” Journal of Sexual Medicine, vol. 7, supplement 5, pp. 362–373, 2010. View at Publisher · View at Google Scholar · View at Scopus
  30. J. E. Mantell, B. S. West, K. Sue et al., “Health care providers: a missing link in understanding acceptability of the female condom,” AIDS Education and Prevention, vol. 23, no. 1, pp. 65–77, 2011. View at Publisher · View at Google Scholar · View at Scopus
  31. E. L. Gollub, “A neglected population: drug-using women and women's methods of HIV/STI prevention,” AIDS Education and Prevention, vol. 20, no. 2, pp. 107–120, 2008. View at Publisher · View at Google Scholar · View at Scopus
  32. E. L. Gollub and Z. Stein, “Living with uncertainty: acting in the best interests of women,” AIDS Research and Treatment, vol. 2012, Article ID 524936, 9 pages, 2012. View at Publisher · View at Google Scholar
  33. C. F. Turner, L. Ku, S. M. Rogers, L. D. Lindberg, J. H. Pleck, and F. L. Sonenstein, “Adolescent sexual behavior, drug use, and violence: increased reporting with computer survey technology,” Science, vol. 280, no. 5365, pp. 867–873, 1998. View at Publisher · View at Google Scholar · View at Scopus
  34. B. T. Mausbach, S. J. Semple, S. A. Strathdee, J. Zians, and T. L. Patterson, “Efficacy of a behavioral intervention for increasing safer sex behaviors in HIV-positive MSM methamphetamine users: results from the EDGE,” Annals of Behavioral Medicine, vol. 34, no. 3, pp. 263–274, 2007. View at Google Scholar
  35. S. A. Strathdee and J. K. Stockman, “Epidemiology of HIV among injecting and non-injecting drug users: current trends and implications for interventions,” Current HIV/AIDS Reports, vol. 7, no. 2, pp. 99–106, 2010. View at Publisher · View at Google Scholar · View at Scopus
  36. S. D. Baral, S. Strömdahl, and C. Beyrer, “The potential uses of preexposure prophylaxis for HIV prevention among people who inject drugs,” Current Opinion in HIV and AIDS, vol. 7, no. 6, pp. 563–568, 2012. View at Google Scholar
  37. Q. A. Karim, S. S. A. Karim, J. A. Frohlich et al., “Effectiveness and safety of tenofovir gel, an antiretroviral microbicide, for the prevention of HIV infection in women,” Science, vol. 329, no. 5996, pp. 1168–1174, 2010. View at Publisher · View at Google Scholar · View at Scopus
  38. Microbicide Trials Network (MTN), “Daily HIV Prevention Approaches Didn’t Work for African Women in the VOICE Study,” 2013, http://www.mtnstopshiv.org/node/4877.
  39. L. Van Damme and M. Szpir, “Current status of topical antiretroviral chemoprophylaxis,” Current Opinion in HIV and AIDS, vol. 7, no. 6, pp. 520–525, 2012. View at Google Scholar